H. M. Brecht

1.3k total citations
26 papers, 959 citations indexed

About

H. M. Brecht is a scholar working on Cardiology and Cardiovascular Medicine, Neurology and Small Animals. According to data from OpenAlex, H. M. Brecht has authored 26 papers receiving a total of 959 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Cardiology and Cardiovascular Medicine, 7 papers in Neurology and 5 papers in Small Animals. Recurrent topics in H. M. Brecht's work include Parkinson's Disease Mechanisms and Treatments (7 papers), Veterinary Medicine and Surgery (5 papers) and Antiplatelet Therapy and Cardiovascular Diseases (4 papers). H. M. Brecht is often cited by papers focused on Parkinson's Disease Mechanisms and Treatments (7 papers), Veterinary Medicine and Surgery (5 papers) and Antiplatelet Therapy and Cardiovascular Diseases (4 papers). H. M. Brecht collaborates with scholars based in Germany, Canada and United States. H. M. Brecht's co-authors include Matthias Lemke, Jacques Genest, Juergen Koester, K. Hayduk, Detlev Ganten, Roger Boucher, Gert Seeger, Sebastian Paus, Ullrich Wüllner and Thomas Klockgether and has published in prestigious journals such as Nature, Science and Journal of the American Society of Nephrology.

In The Last Decade

H. M. Brecht

25 papers receiving 886 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
H. M. Brecht Germany 13 384 245 194 182 180 26 959
J L Montastruc France 13 154 0.4× 85 0.3× 69 0.4× 188 1.0× 225 1.3× 43 702
Carrie G. Markgraf United States 16 491 1.3× 75 0.3× 156 0.8× 385 2.1× 434 2.4× 28 1.5k
Diane Lane United States 17 221 0.6× 66 0.3× 78 0.4× 346 1.9× 452 2.5× 30 1.3k
Kunihiro Isse Japan 12 200 0.5× 24 0.1× 238 1.2× 115 0.6× 248 1.4× 28 1.0k
J. O. SKARPHEDINSSON Sweden 18 110 0.3× 206 0.8× 44 0.2× 103 0.6× 137 0.8× 32 757
Pablo Garrido‐Gil Spain 26 486 1.3× 476 1.9× 51 0.3× 633 3.5× 595 3.3× 45 1.7k
Richard J. Konkol United States 21 145 0.4× 25 0.1× 80 0.4× 290 1.6× 352 2.0× 38 1.1k
Linda Vedders United States 12 1.1k 2.8× 99 0.4× 117 0.6× 255 1.4× 313 1.7× 13 1.7k
Lewis S. Freedman United States 18 119 0.3× 45 0.2× 116 0.6× 218 1.2× 291 1.6× 29 785

Countries citing papers authored by H. M. Brecht

Since Specialization
Citations

This map shows the geographic impact of H. M. Brecht's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by H. M. Brecht with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites H. M. Brecht more than expected).

Fields of papers citing papers by H. M. Brecht

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by H. M. Brecht. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by H. M. Brecht. The network helps show where H. M. Brecht may publish in the future.

Co-authorship network of co-authors of H. M. Brecht

This figure shows the co-authorship network connecting the top 25 collaborators of H. M. Brecht. A scholar is included among the top collaborators of H. M. Brecht based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with H. M. Brecht. H. M. Brecht is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lemke, Matthias, H. M. Brecht, Juergen Koester, & Heinz Reichmann. (2006). Effects of the dopamine agonist pramipexole on depression, anhedonia and motor functioning in Parkinson's disease. Journal of the Neurological Sciences. 248(1-2). 266–270. 105 indexed citations
2.
Lemke, Matthias, H. M. Brecht, Juergen Koester, Peter H. Kraus, & Heinz Reichmann. (2005). Anhedonia, Depression, and Motor Functioning in Parkinson’s Disease During Treatment With Pramipexole. Journal of Neuropsychiatry. 17(2). 214–220. 112 indexed citations
3.
Paus, Sebastian, Gert Seeger, H. M. Brecht, et al.. (2004). Association study of dopamine D2, D3, D4 receptor and serotonin transporter gene polymorphisms with sleep attacks in Parkinson's disease. Movement Disorders. 19(6). 705–707. 30 indexed citations
4.
Paus, Sebastian, H. M. Brecht, Jürgen Köster, et al.. (2003). Sleep attacks, daytime sleepiness, and dopamine agonists in Parkinson's disease. Movement Disorders. 18(6). 659–667. 216 indexed citations
5.
Paus, Sebastian, H. M. Brecht, Thomas Klockgether, & Ullrich Wüllner. (2003). Reply: Sleep attacks may not be a side effect of dopaminergic medication. Movement Disorders. 18(12). 1571–1571. 1 indexed citations
6.
Reichmann, Heinz, H. M. Brecht, P. H. Kraus, & Matthias Lemke. (2002). Pramipexol bei der Parkinson-Krankheit Ergebnisse einer Anwendungsbeobachtung. Der Nervenarzt. 73(8). 745–750. 12 indexed citations
7.
Thaiss, Friedrich, et al.. (1994). Platelet-activating factor receptor antagonist improves renal function and glomerular lesions in renal ablation.. PubMed. 124(6). 775–81. 6 indexed citations
8.
Brecht, H. M., et al.. (1991). Pharmacodynamics, pharmacokinetics and safety profile of the new platelet-activating factor antagonist apafant in man.. PubMed. 41(1). 51–9. 13 indexed citations
9.
Stahl, Rolf A.K., et al.. (1991). The platelet activating factor receptor antagonist WEB 2170 improves glomerular hemodynamics and morphology in a proliferative model of mesangial cell injury.. Journal of the American Society of Nephrology. 2(1). 37–44. 20 indexed citations
10.
Heuer, H., et al.. (1989). Safety, tolerability., and pharmacologic activity of multiple doses of the new platelet activating factor antagonist WEB 2086 in human subjects. Clinical Pharmacology & Therapeutics. 45(3). 270–276. 24 indexed citations
11.
Heuer, H., et al.. (1988). Effect of peroral web 2086 on ex vivo platelet activating factor induced platelet aggregation in man. Prostaglandins. 35(5). 836–836. 5 indexed citations
12.
Heuer, H., et al.. (1988). Inhibitory effect of oral WEB 2086, a novel selective PAF-acether antagonist, on ex vivo platelet aggregation. European Journal of Clinical Pharmacology. 35(3). 237–240. 17 indexed citations
13.
14.
Brecht, H. M., et al.. (1973). Effect of Adrenal Arterial Infusion of Different Mg2+ Concentrations on the Spontaneous Release of Catecholamines in the Anesthetized Dog. Experimental Biology and Medicine. 143(1). 39–43. 1 indexed citations
15.
Barbeau, A., et al.. (1972). Effect of a magnesium-deficient diet on the striatal content of amines in the dog. Cellular and Molecular Life Sciences. 28(3). 289–291. 6 indexed citations
16.
Rojo-Ortega, J. M., H. M. Brecht, & Jacques Genest. (1971). Effects of magnesium-deficient diet on the thyroid C cells and parathyroid gland of the dog. Virchows Archiv B Cell Pathology. 7(1). 81–9. 9 indexed citations
17.
Ganten, Detlev, K. Hayduk, H. M. Brecht, et al.. (1971). Angiotensin-Forming Enzyme in Brain Tissue. Science. 173(3991). 64–65. 230 indexed citations
18.
Hayduk, K., Detlev Ganten, H. M. Brecht, R. Boucher, & Jacques Genest. (1970). Erh�hte Reninausscheidung im Urin der isch�mischen Niere bei experimenteller einseitiger Nierenarterienstenose des Hundes. Journal of Molecular Medicine. 48(18). 1124–1126. 4 indexed citations
19.
Hayduk, K., H. M. Brecht, A O Vladutiu, et al.. (1970). Renin activity and norepinephrine, cation, and water contents of cardiovascular tissue of dogs with congestive heart failure and ascites. Canadian Journal of Physiology and Pharmacology. 48(7). 463–468. 22 indexed citations
20.
Ganten, Detlev, K. Hayduk, H. M. Brecht, Roger Boucher, & Jacques Genest. (1970). Evidence of Renin Release or Production in Splanchnic Territory. Nature. 226(5245). 551–552. 61 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by J L Montastruc Breakdown of academic impact, for papers by Carrie G. Markgraf Breakdown of academic impact, for papers by Diane Lane Breakdown of academic impact, for papers by Kunihiro Isse Breakdown of academic impact, for papers by J. O. SKARPHEDINSSON Breakdown of academic impact, for papers by Pablo Garrido‐Gil Breakdown of academic impact, for papers by Richard J. Konkol Breakdown of academic impact, for papers by Linda Vedders Breakdown of academic impact, for papers by Lewis S. Freedman
Rankless by CCL
2026